Molecular Partners AG (MOLN) Financials
MOLN Assets vs Liabilities
Date | Assets | Liabilities |
---|---|---|
2023-09-30 | 238.2 million | 23.9 million |
2023-06-30 | 256.4 million | 27.3 million |
2023-03-31 | 267.5 million | 24.5 million |
2022-12-31 | 283.7 million | 29.3 million |
MOLN Free Cash Flow and Stock based compensation
Graph available only for supporters. Become a supporter to see it.
Date | Free Cash Flow | Stock based compensation |
---|---|---|
2023-09-30 | -14.6 million | 1.1 million |
2023-06-30 | -15.0 million | 1.5 million |
2023-03-31 | -18.3 million | 1.9 million |
2022-12-31 | -16.1 million | 1.2 million |
MOLN Net Income
No data available :(
MOLN Cash and Debt
Graph available only for supporters. Become a supporter to see it.
Date | Cash | Debt | Capital Lease |
---|---|---|---|
2023-09-30 | 225.7 million | - | 4.3 million |
2023-06-30 | 242.7 million | - | 4.7 million |
2023-03-31 | 254.2 million | - | 5.0 million |
2022-12-31 | 269.5 million | - | 5.2 million |
MOLN Shares Outstanding
MOLN Expenses
Graph available only for supporters. Become a supporter to see it.
Date | Capex | R&D | G&A | S&M |
---|---|---|---|---|
2023-09-30 | 170388 | 12.7 million | 4.8 million | - |
2023-06-30 | 202447 | 12.9 million | 5.2 million | - |
2023-03-31 | 175052 | 13.9 million | 982085 | 1.4 million |
2022-12-31 | 680315 | 13.2 million | 5.4 million | - |
MOLN Cost of Revenue
Graph available only for supporters. Become a supporter to see it.
Date | Revenue | Cost of Revenue |
---|---|---|
2023-09-30 | 2.8 million | 12.7 million |
2023-06-30 | 461625 | 12.9 million |
2023-03-31 | 3.3 million | 13.9 million |
2022-12-31 | 2.9 million | 13.2 million |
MOLN
Price: $3.98
52 week price:
Earnings Per Share: -2.10 USD
P/E Ratio: -2.11
Exchange: NMS
Sector: Healthcare
Industry: Biotechnology
Volume: 4126
Market Capitalization: 129.8 million